Sunshine Biopharma- Warrants (15/02/2027) Other Current Liabilities

As of the most recent data (June 2026), SBFMW shows a other current liabilities of $500K. That compares with $73K in the prior-year period — up 579.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SBFMW's other current liabilities is now $500K (was $73K) — a 579.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sunshine Biopharma- Warrants (15/02/2027) is outperforming or lagging.

Tracking SBFMW's other current liabilities over time shows whether Sunshine Biopharma- Warrants (15/02/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $500K That compares with $73K in the prior-year period — up 579.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Sunshine Biopharma- Warrants (15/02/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $500K) with ownership activity and broader fundamentals.

Sunshine Biopharma- Warrants (15/02/2027)'s other current liabilities is $500K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.